Page 382 - Binder2

Who is Impacted by Collapse?

Those Who What They Lose
Lose
Revenue from in-person administration
Infusion centers
and facility fees
Specialty Exclusivity and control over high-cost
pharmacies distribution channels
Pricing power once cold-chain logistics
Manufacturers and complexity no longer justify
premiums
Gatekeeping levers when patients
Insurers bypass pre-authorizations and clinical
checkpoints

Those Who What They Gain
Gain
Access to therapies on their own terms—
Patients
at home, with dignity and autonomy
Freedom to focus on care, not infusions—
Clinicians
more time for guidance and connection
Opportunities to grow and distribute their
Communities
own medicines locally and sustainably
Durable, low-cost treatments with higher
Payers
adherence and fewer downstream costs

380